MVP Group Vaccination Program Update
by Kim Santiago
The MVP Group COVID-19 Vaccination Program is part of each member Company’s social and moral responsibility in ensuring and providing the best protection for its employees. This program is also in line with the MVP Group’s commitment to support the government’s pandemic response and accelerate vaccination efforts in our country.
The MVP Group purchased 50,000 doses of AstraZeneca and Novavax Vaccines and 1 million doses of Moderna Vaccines for its employees, along with their respective dependents and household members. These vaccines will arrive in small batches.
We are expecting 14,000 doses of Moderna vaccines and 50,000 doses – OF ? WHICH VACCINE? – to arrive first. Upon their arrival, the MVP Group Vaccine Task Force will begin the MVP Group-wide Vaccination Program.
Priority groupings for covered individuals in this program shall be consistent with the prioritization framework and guidelines set by the DOH.
|Vaccination Sites||Projected Capacity per Day||Lead MPHHI Hospital||Alternate Hospital/s|
|Meralco||1,000-1,350||Cardinal Santos Medical Center||OLLH, MVMC, JDMH|
|PLDT Sta. Ana||500-900||Our Lady of Lourdes||MDH|
|Maynilad Balara||500-900||De Los Santos Medical Center||MVMC, JDMH|
|Smart Tower||300-450||Makati Medical Center||AHI, MDH|
|NLEX Sta. Rita||500-900||Sacred Heart Hospital of Malolos|
MVP Group Vaccination Platform
Source: MVP Group COVID-19 Vaccination Program Playbook
Did you like this article? Give it a clap!